207 related articles for article (PubMed ID: 15985052)
21. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
Khan MK; Khan MF
Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
[TBL] [Abstract][Full Text] [Related]
22. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
[TBL] [Abstract][Full Text] [Related]
23. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration.
Madu AA; Mayers M; Perkins R; Liu W; Drusano GL; Aswani R; Madu CN; Miller MH
Exp Eye Res; 1996 Aug; 63(2):129-36. PubMed ID: 8983970
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
[TBL] [Abstract][Full Text] [Related]
25. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
Albarellos GA; Kreil VE; Landoni MF
J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
[TBL] [Abstract][Full Text] [Related]
27. Comparative bioavailability of two brands of ciprofloxacin.
Seth SD; Beotra A; Seth S
J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Davis JL; Papich MG; Weingarten A
J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
[TBL] [Abstract][Full Text] [Related]
29. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
[TBL] [Abstract][Full Text] [Related]
30. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats.
Marín P; Escudero E; Fernández-Varón E; Cárceles CM
J Vet Pharmacol Ther; 2007 Feb; 30(1):74-9. PubMed ID: 17217405
[TBL] [Abstract][Full Text] [Related]
32. Diclofenac concentrations in defined tissue layers after topical administration.
Müller M; Mascher H; Kikuta C; Schäfer S; Brunner M; Dorner G; Eichler HG
Clin Pharmacol Ther; 1997 Sep; 62(3):293-9. PubMed ID: 9333105
[TBL] [Abstract][Full Text] [Related]
33. Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers.
Hassan Y; Alfadly SO; Azmin MN; Peh KK; Tan TF; Noorizan AA; Ismail O
Singapore Med J; 2007 Sep; 48(9):819-23. PubMed ID: 17728962
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of ciprofloxacin in eels by high-performance liquid chromatography with fluorescence detection.
Guo L; Xie Z; Lin X; Wu X; Qiu B; Zhang Y; You H; Chen G
Anal Biochem; 2005 Jun; 341(2):275-9. PubMed ID: 15907873
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
[TBL] [Abstract][Full Text] [Related]
36. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L
Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681
[TBL] [Abstract][Full Text] [Related]
37. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
Khan MK; Khan MF
Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
Davis JL; Foster DM; Papich MG
J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
[TBL] [Abstract][Full Text] [Related]
40. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
Overholser BR; Kays MB; Forrest A; Sowinski KM
J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
